Looking forward to seeing any video of Gary presenting at Fremantle's Bioshares Biotech Summit last weekend (12-13 July). Of course there's the associated presentation as per the link below.
https://www.bioshares.com.au/file/75/view/S110Syntara.pdf
Surely SNT has to be recognised soon enough for what it has to offer - 4 x Ph2 studies underway, Fiona Wood stating that the scar healing from SNT-6302 is 'unprecedented', and a company that is fully-funded until mid 2025!
Starting MC at $100m one would think (so 8-9c a share). It seems the market just needs to gain some confidence again after previous turmoil and the change from Pharmaxis to Syntara in Dec?
Add to My Watchlist
What is My Watchlist?
